Heparin Sodium and Sodium Chloride (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Heparin Sodium and Sodium Chloride drug offered from Baxter Healthcare Corporation. This Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | heparin sodium |
SUBSTANCE NAME: | HEPARIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
START MARKETING DATE: | 2017-10-25 |
END MARKETING DATE: | 0000-00-00 |
Heparin Sodium and Sodium Chloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Heparin Sodium and Sodium Chloride from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2000([iU]/1000mL) |
START MARKETING DATE: | 2017-10-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-9552_cf6ce51b-dc0c-424e-9fac-e4713bd095ed |
PRODUCT NDC: | 0338-9552 |
APPLICATION NUMBER: | |
Other HEPARIN SODIUM Pharmaceutical Manufacturers / Labelers: